(Q34427746)

2 August 2017

1 reference

title

Tamoxifen resistance in breast cancer: elucidating mechanisms (English)

1 reference

2 August 2017

1 reference

1 reference

Dorssers LC

1

1 reference

2 August 2017

Van der Flier S

2

1 reference

2 August 2017

Brinkman A

3

1 reference

2 August 2017

van Agthoven T

4

1 reference

2 August 2017

Veldscholte J

5

1 reference

2 August 2017

Berns EM

6

1 reference

2 August 2017

Klijn JG

7

1 reference

2 August 2017

Beex LV

8

1 reference

2 August 2017

Foekens JA

9

1 reference

2 August 2017

publication date

1 January 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

61

1 reference

2 August 2017

issue

12

1 reference

2 August 2017

page(s)

1721-1733

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200161120-00004

2 August 2017

exact match

0 references

cites work

Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis

1 reference

12 December 2020

Mechanisms of hormone resistance in breast cancer

1 reference

12 December 2020

Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue

1 reference

12 December 2020

A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer

1 reference

12 December 2020

Basic guide to the mechanisms of antiestrogen action

1 reference

12 December 2020

The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients*

1 reference

12 December 2020

Effects of anti-estrogens on bone in castrated and intact female rats

1 reference

12 December 2020

BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas.

1 reference

12 December 2020

cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo

1 reference

12 December 2020

Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions

1 reference

12 December 2020

Molecular classification of cutaneous malignant melanoma by gene expression profiling

1 reference

12 December 2020

Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells

1 reference

12 December 2020

Mechanisms of tamoxifen resistance

1 reference

12 December 2020

Recent advances in endocrine therapy of breast cancer

1 reference

12 December 2020

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

12 December 2020

ER beta: identification and characterization of a novel human estrogen receptor

1 reference

12 December 2020

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

Breast cancer: relevance of estrogen receptor determination at relapse

1 reference

12 December 2020

Species-specific pharmacology of antiestrogens: role of metabolism

1 reference

12 December 2020

Clinical studies of apoptosis and proliferation in breast cancer

1 reference

12 December 2020

Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model

1 reference

12 December 2020

Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.

1 reference

12 December 2020

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

1 reference

12 December 2020

Use of tamoxifen for breast cancer: twenty-eight years later

1 reference

12 December 2020

Variant human breast tumor estrogen receptor with constitutive transcriptional activity

1 reference

12 December 2020

Steroid/thyroid receptor-like proteins with oncogenic potential: a review

1 reference

12 December 2020

Nuclear receptor coregulators: cellular and molecular biology

1 reference

12 December 2020

Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.

1 reference

12 December 2020

Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle

1 reference

12 December 2020

Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer

1 reference

12 December 2020

Molecular chaperone interactions with steroid receptors: an update

1 reference

12 December 2020

Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment

1 reference

12 December 2020

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

1 reference

12 December 2020

Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment.

1 reference

12 December 2020

Cellular basis of breast cancer susceptibility.

1 reference

12 December 2020

Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations

1 reference

12 December 2020

Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials

1 reference

12 December 2020

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

12 December 2020

Molecular portraits of human breast tumours

1 reference

12 December 2020

Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients.

1 reference

12 December 2020

Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.

1 reference

12 December 2020

Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells.

1 reference

12 December 2020

Exploring the new world of the genome with DNA microarrays

1 reference

12 December 2020

Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland

1 reference

12 December 2020

Endocrine resistance in advanced breast cancer

1 reference

12 December 2020

Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity

1 reference

12 December 2020

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Expression of estrogen receptor beta messenger RNA variant in breast cancer

1 reference

12 December 2020

Prognostic significance of oestrogen receptor beta in breast cancer

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice

1 reference

12 December 2020

Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.

1 reference

12 December 2020

Estrogen receptor-positive proliferating cells in the normal and precancerous breast.

1 reference

12 December 2020

Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer

1 reference

12 December 2020

Oestrogen receptor expression in the normal and pre-cancerous breast

1 reference

12 December 2020

Differences in estrogen receptor alpha variant messenger RNAs between normal human breast tissue and primary breast carcinomas

1 reference

12 December 2020

A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog

1 reference

12 December 2020

Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis

1 reference

12 December 2020

Tamoxifen in the treatment of breast cancer

1 reference

12 December 2020

Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer

1 reference

12 December 2020

The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth

1 reference

12 December 2020

New Hormonal Therapies for Breast Cancer.

1 reference

12 December 2020

A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity

1 reference

12 December 2020

Steroid-hormone receptors in nonpalpable and more advanced stages of breast cancer. A contribution to the biology and natural history of carcinoma of the female breast

1 reference

12 December 2020

p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer

1 reference

12 December 2020

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

12 December 2020

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

1 reference

12 December 2020

Growth factors in breast cancer

1 reference

12 December 2020

Impact of progesterone receptor on cell-fate decisions during mammary gland development

1 reference

12 December 2020

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer

1 reference

12 December 2020

The nuclear receptor superfamily: the second decade

1 reference

12 December 2020

Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells

1 reference

12 December 2020

Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells

1 reference

12 December 2020

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

12 December 2020

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy

1 reference

12 December 2020

Detection of estrogen receptor-beta mRNA in breast cancer using RT-PCR

1 reference

12 December 2020

Identification of the breast cancer susceptibility gene BRCA2

1 reference

12 December 2020

Nuclear hormone receptor coregulators in action: diversity for shared tasks

1 reference

12 December 2020

Endocrine pharmacology of antiestrogens as antitumor agents

1 reference

12 December 2020

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

12 December 2020

Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer

1 reference

12 December 2020

Pathological studies of apoptosis in the normal breast

1 reference

12 December 2020

Antiestrogen resistance in ER positive breast cancer cells

1 reference

12 December 2020

Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells

1 reference

12 December 2020

The significance of heregulin in breast cancer tumor progression and drug resistance

1 reference

12 December 2020

Receptors, growth factors and steroid insensitivity of tumours

1 reference

12 December 2020

Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells

1 reference

12 December 2020

Expression profiling using cDNA microarrays

1 reference

12 December 2020

Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer

1 reference

12 December 2020

Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site

1 reference

12 December 2020

Endogenous hormones and breast cancer risk

1 reference

12 December 2020

Use of aromatase inhibitors in breast carcinoma

1 reference

12 December 2020

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

12 December 2020

Antiestrogen action and growth factor regulation

1 reference

12 December 2020

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

12 December 2020

Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions

1 reference

12 December 2020

Transforming growth factor-beta in breast cancer: a working hypothesis

1 reference

12 December 2020

Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy

1 reference

12 December 2020

Towards a molecular basis for tamoxifen resistance in breast cancer

1 reference

12 December 2020

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

1 reference

12 December 2020

Retroviral Mutagenesis of Cellular Oncogenes: A Review with Insights into the Mechanisms of Insertional Activation

1 reference

12 December 2020

William L. McGuire Memorial Symposium. Drug resistance to tamoxifen during breast cancer therapy

1 reference

12 December 2020

Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor

1 reference

12 December 2020

Dissociation between steroid receptor expression and cell proliferation in the human breast.

1 reference

12 December 2020

Statistical analysis of array expression data as applied to the problem of tamoxifen resistance

1 reference

12 December 2020

Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.

1 reference

12 December 2020

Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.

1 reference

12 December 2020

The transition from hyperplasia to invasive carcinoma of the breast

1 reference

12 December 2020

Selective estrogen receptor modulators: structure, function, and clinical use.

1 reference

12 December 2020

Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors

1 reference

12 December 2020

Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.

1 reference

12 December 2020

Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells

1 reference

12 December 2020

Antiestrogens--tamoxifen, SERMs and beyond

1 reference

12 December 2020

Linking gene expression patterns to therapeutic groups in breast cancer

1 reference

12 December 2020

Estrogen receptor mutations in tamoxifen-resistant breast cancer

1 reference

12 December 2020

The cytokeratin profile of medullary carcinoma of the breast

1 reference

12 December 2020

Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer?

1 reference

12 December 2020

Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression

1 reference

12 December 2020

Retroviral insertional mutagenesis as a strategy to identify cancer genes

1 reference

12 December 2020

Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression

1 reference

12 December 2020

Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.

1 reference

12 December 2020

Hormone resistance, invasiveness, and metastatic potential in breast cancer.

1 reference

12 December 2020

Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation

1 reference

12 December 2020

BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells

1 reference

12 December 2020

Integrin signalling: a new Cas(t) of characters enters the stage

1 reference

12 December 2020

Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

1 reference

12 December 2020

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

12 December 2020

Oestrogen/growth factor cross-talk in breast carcinoma: a specific target for novel antioestrogens

1 reference

12 December 2020

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

12 December 2020

MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice

1 reference

12 December 2020

Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse

1 reference

12 December 2020

Oestrogen receptor mutants and variants in breast cancer

1 reference

12 December 2020

Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study

1 reference

12 December 2020

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

12 December 2020

Mammary epithelial stem cells: our current understanding

1 reference

12 December 2020

Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer

1 reference

12 December 2020

Oestrogen receptor: a stable phenotype in breast cancer

1 reference

12 December 2020

Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer

1 reference

12 December 2020

A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner

1 reference

12 December 2020

Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis

1 reference

12 December 2020

Reducing the risk of breast cancer

1 reference

12 December 2020

Tamoxifen, Raloxifene, and the Prevention of Breast Cancer1

1 reference

12 December 2020

William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer

1 reference

12 December 2020

Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer

1 reference

12 December 2020

Steroid hormone receptors: many actors in search of a plot

1 reference

12 December 2020

The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast

1 reference

12 December 2020

Progestin action and progesterone receptor structure in human breast cancer: a review.

1 reference

12 December 2020

Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer

1 reference

12 December 2020

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

12 December 2020

Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal

1 reference

12 December 2020

Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration.

1 reference

12 December 2020

Molecular mechanisms of antiestrogen action in breast cancer

1 reference

12 December 2020

Tamoxifen, raloxifene, and the prevention of breast cancer

1 reference

12 December 2020

10.2165/00003495-200161120-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1021792585

0 references

1 reference